Etiometry Earns Top Honors – Major Recognition Nearby and Nationally
News and Press Releases
BOSTON, December 17, 2018 – Improving the quality of critical care has always been their top priority but earning accolades along the way is an added bonus. In 2018, Etiometry earned major recognition and funding from prestigious organizations nearby and nationally.
Competing against 213 companies from five of the six New England states can be a daunting task for any business owner; but Etiometry was up for the challenge. After narrowing the competition to 50 semi-finalists, then 20 finalists, Etiometry’s COO Evan Butler presented the company’s mission in front of a 64-judge panel. Several months of deliberation went by but, ultimately, Etiometry took top honors as one of the eight winners of the 2018 New England Business Association’s Innovation Awards. “As the Circle of Excellence welcomes the class of 2018, I can honestly say it is one of our best yet”, said New England Innovation Awards Committee Chairman, Todd Faber, President, The Faber Group, in a press release.
The largest source of funding for medical research in the world continues to see value in Etiometry’s work. For the third time in four years, The National Institutes of Health awarded Etiometry nearly one million dollars to continue their groundbreaking progress in dynamic analytics for critical care facilities. The latest grant award aims to investigate how Etiometry’s FDA-cleared Risk Analytics Algorithm for Inadequate Delivery of Oxygen, known as the IDO2 Index, can best be used to inform treatment decisions. With the help of their clinical partners, the team is designing and deploying protocols and studying their critical care outcomes; such as length of stay, time on ventilation, and ECMO events. As a Boston-based company, Etiometry is proud to contribute to the city’s unparalleled 23-year record for most NIH funds.
About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
Leveraging AI in Learning Health Systems to improve patient outcomes, reduce costs
Published on DOTmed, by Etiometry’s CEO Shane Cooke It’s no secret that hospitals are facing some of their toughest challenges ever. Workforce shortages and burnout are commonplace and operating budgets are tight. Hospital leaders need to find increasingly creative ways to address these challenges and set themselves up for long-term success. Enter artificial intelligence (AI) technology. […]
HIMSS TV: Etiometry on AI’s role in clinical decision support
In this HIMSS TV interview, Etiometry CEO Shane Cooke dives into the transformative role of AI in clinical decision support—not as a replacement for clinicians, but as a powerful tool to enhance their expertise. Watch the full interview to see how he breaks down how predictive analytics can detect patient deterioration earlier, why AI-driven insights […]
Etiometry Achieves 10th FDA Clearance for Critical Care Platform
FDA Clearance Solidifies Etiometry’s Regulatory Leadership and Cybersecurity Excellence THURSDAY, FEB. 27, 2025- Boston, MA- As cybersecurity threats in healthcare continue to rise, and with the U.S. Food and Drug Administration (FDA) implementing stricter guidelines for cybersecurity compliance, Etiometry, the leader in clinical decision support software for high-acuity units, has received its 10th FDA clearance. This […]